Almirall in Numbers. Our devotion to science and people can be measured +100 Countries where we help patients +2,027 Employees (54% women) 14 Affiliates Present within Europe and US. €124,2 MM Organic R&D and in-licensing payments. €985.7 MM Net Sales. Our suppliers, key to deploy our Purpose.

Almirall is a leading skin-health focused global pharmaceutical company based in Barcelona that partners with healthcare professionals, applying Science to provide medical solutions to patients and future generations.

Almirall products by country. Check which Almirall products are available in your country by selecting from the list below

November 17 th, 2023 – Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, announced today that the European Commission (EC) has approved EBGLYSS (lebrikizumab) for the treatment of adult and adolescent patients (12 years and older with a body weight of at least 40 kg) with moderate-to-severe atopic ...

Almirall supports the mission of the UN Global Compact to mobilise a global movement of sustainable companies and stakeholders to create the world we want. We have conducted an in-depth analysis of the goals and targets that we can make the most productive contribution to.

Zgodnie z Kodeksem Dobrych Praktyk Europejskiej Federacji Przemysłu i Stowarzyszeń Farmaceutycznych (EFPIA), a także przepisami krajowymi, firma Almirall udostępnia informacje dotyczące udzielanego przez nią wsparcia na rzecz organizacji pacjentów.

2025年1月14日 · Almirall, S.A. (ALM) San Francisco 14th January 2025 Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook.

Almirall’s Nine-month 2024 Results: Almirall reports strong performance at Q3 2024 - driven by successful commercial execution of the dermatology portfolio, fuelled by biologics growth

Several criteria are used to classify the different types of skin.For example, Fitzpatrick's classification, first described in 1975, is based on skin color and its response to sun exposure. It is used to determine the proper type of sun protection factor or to predict the risk of skin cancer, among others.However, from a cosmetic point of view, skin is classified according to several …

More than skin. We know that skin is important. But we also believe if we want to change the lives of patients, we must work on solutions to treat conditions that go beyond just skin.